TNSN00078A1 - Un supplement dietetique derivant de laits fermentes pour la prevention de l'osteoporose - Google Patents

Un supplement dietetique derivant de laits fermentes pour la prevention de l'osteoporose

Info

Publication number
TNSN00078A1
TNSN00078A1 TNTNSN00078A TNSN00078A TNSN00078A1 TN SN00078 A1 TNSN00078 A1 TN SN00078A1 TN TNSN00078 A TNTNSN00078 A TN TNSN00078A TN SN00078 A TNSN00078 A TN SN00078A TN SN00078 A1 TNSN00078 A1 TN SN00078A1
Authority
TN
Tunisia
Prior art keywords
grains
weight
mixture
polysaccharide
temperature
Prior art date
Application number
TNTNSN00078A
Other languages
English (en)
Inventor
A Weissmahr Joseph
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of TNSN00078A1 publication Critical patent/TNSN00078A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1232—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt in powdered, granulated or dried solid form
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

UN PROCEDE EST DECRIT POUR LA FABRICATION DE SUPPLEMENTS DIETETIQUES (INTEGRATEURS ALIMENTAIRES) PAR FERMENTATION NATURELLE COMPORTANT a) LA PREPARATION D'UN MELANGE SOUS UNE TEMPERATURE DE 18°C, CONTENANT UN OU PLUSIEURS TYPES DE LAITS PASTEURISES D'ORIGINE ANIMALE ; b) L'INTRODUCTION DANS CE "MELANGE DE BASE" DE 1.5 A 4.5 % EN POIDS DE "BACTERIES BENEFIQUES" FORMEES ESSENTIELLEMENT A BASE DE "GRAINS" DE POLYSACCHARIDE ; c) LE MAINTIEN DU MELANGE AINSI OBTENU SOUS UNE TEMPERATURE DE 18 A 25°C PENDANT UNE PERIODE DE 6 A 12 HEURES, PUIS L'ADJONCTION D'UNE QUANTITE DE 1 A 3 % EN POIDS D'UNE DEUXIEME QUANTITE DE "GRAINS" DE POLYSACCHARIDE, PRINCIPALEMENT CONSTITUEE DE LEVURES ; d) LE MAINTIEN DU MELANGE AINSI OBTENU SOUS UNE TEMPERATURE DE 18 A 25 % PENDANT UNE DEUXIEME PERIODE DE 6 A 12 HEURES, PUIS L'ADJONCTION DE NOUVEAU DE 2.5 A 6.5 % EN POIDS DE "GRAINS" CONSTITUE ESSENTIELLEMENT DE LEVURES, PUIS L'ADJONCTION DE CERTAINS MINERAUX (CALCIUM, MAGNESIUM, ETC) SUIVANT UNE PROPORTION DE 0.2 A 1.2% EN POIDS. e) LA SEPARATION PAR FILTRATION DES DIFFERENTS COMPOSANTS DE LA SUBSTANCE, DONT UNE "MATRICE RESIDUELLE" COMPOSEE DE GRAINS DE POLYSACCHARIDES CONTENANT DES BACTERIES ET DES LEVURES ; f) LE SECHAGE DE LA SUBSTANCE ET LA FILTRATION ULTERIEURE POUR OBTENIR UNE POUDRE FINE ; g) LA PREPARATION DE DIFFERENTS SUPPLEMENTS DIETETIQUES, PRESENTES SOUS FORME DE COMPRIMES OU "SACHETS" OU AUTRES FORMULATIONS, UTILISABLES DANS LE TRAITEMENT DE L'OSTEOPOROSE ET D'AUTRES ETATS PATHOLOGIQUES DEGENERATIFS.
TNTNSN00078A 1999-04-13 2000-04-13 Un supplement dietetique derivant de laits fermentes pour la prevention de l'osteoporose TNSN00078A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH68399 1999-04-13

Publications (1)

Publication Number Publication Date
TNSN00078A1 true TNSN00078A1 (fr) 2005-11-10

Family

ID=4192730

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN00078A TNSN00078A1 (fr) 1999-04-13 2000-04-13 Un supplement dietetique derivant de laits fermentes pour la prevention de l'osteoporose

Country Status (24)

Country Link
US (1) US6511685B1 (fr)
EP (1) EP1085816B1 (fr)
JP (1) JP4231208B2 (fr)
KR (1) KR20010072587A (fr)
CN (1) CN1300187A (fr)
AR (1) AR023477A1 (fr)
AT (1) ATE249147T1 (fr)
AU (1) AU775104B2 (fr)
BR (1) BR0006040A (fr)
CA (1) CA2334877C (fr)
DE (1) DE60005104T2 (fr)
DK (1) DK1085816T3 (fr)
EE (1) EE200000713A (fr)
ES (1) ES2204569T3 (fr)
HU (1) HUP0103895A3 (fr)
IL (1) IL139853A0 (fr)
IS (1) IS5741A (fr)
NO (1) NO20006284L (fr)
PL (1) PL344670A1 (fr)
PT (1) PT1085816E (fr)
SK (1) SK18862000A3 (fr)
TN (1) TNSN00078A1 (fr)
TR (1) TR200003689T1 (fr)
WO (1) WO2000060950A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100866008B1 (ko) * 1999-10-19 2008-10-29 메이지 데어리즈 코포레이션 대사성 골질환의 예방 치료약
SE0201214D0 (sv) * 2002-04-23 2002-04-23 Jafar Mahdavi Multicultural fermented yoghurt
GB0217225D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
RU2338511C2 (ru) * 2003-04-09 2008-11-20 Дольхаи Клиника Эгесшегидьи Кфт. Композиция для половой гигиены
JP5048246B2 (ja) * 2003-08-26 2012-10-17 日本ケフィア株式会社 スキンケア用の内服組成物
EP1806976B1 (fr) * 2004-10-22 2014-01-29 Unilever N.V. Adjuvant culinaire granulaire renfermant des capsules microbiennes, et cubes et pastilles contenant un tel adjuvant culinaire granulaire
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
DE102005053725A1 (de) * 2005-11-10 2007-05-24 St. Leonhardsquelle Gmbh & Co. Kg Milchprodukt umfassend Stutenmilch und Ziegenmilch, Verfahren zu dessen Herstellung und deren Verwendung
CA2686922C (fr) 2007-05-09 2015-06-30 Nestec S.A. Compositions de fruit ou de legume aerees, lyophilisees et leurs procedes de fabrication
EP2154982B1 (fr) 2007-05-09 2014-06-04 Nestec S.A. Compositions lyophilisées et aérées à base de produits laitiers ou de substituts de produits laitiers et leurs procédés de fabrication
KR100940125B1 (ko) * 2007-08-24 2010-02-02 국민대학교산학협력단 락토바실러스 카세이에 의한 우유 발효물을 유효성분으로포함하는 골 대사 개선용 조성물
ITMI20122267A1 (it) * 2012-12-28 2014-06-29 Granarolo S P A Miscela aromatizzante per la produzione di mozzarelle.
DE102017202134A1 (de) 2017-02-10 2018-08-16 Intercell Pharma Gmbh Präparat zur Behandlung der nachteiligen Begleiterscheinungen von Magensäureblockern
TWI604052B (zh) 2017-02-20 2017-11-01 景岳生物科技股份有限公司 促進骨質再生的植物乳桿菌菌株ｇｍｎｌ－６６２及其組合物
CN108624520B (zh) * 2017-03-16 2022-01-25 景岳生物科技股份有限公司 促进骨质再生的植物乳杆菌菌株gmnl-662及其组合物
CN108486018B (zh) * 2018-05-03 2021-05-11 上海理工大学 一种具有缓解骨吸收症状的短乳杆菌
CA3111795A1 (fr) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methodes et compositions pour le traitement de maladie musculo-squelettiques
EP3986163A2 (fr) * 2019-06-19 2022-04-27 Solarea Bio, Inc. Compositions microbiennes et procédés de production d'assemblages probiotiques améliorés
WO2023092150A1 (fr) * 2021-11-22 2023-05-25 Solarea Bio, Inc. Méthodes et compositions pour le traitement de maladies musculo-squelettiques, le traitement d'une inflammation et la prise en charge de symptômes de la ménopause

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1349300A (fr) * 1962-11-27 1964-01-17 Eurorga Produit alimentaire en provenance du lait
EP0148300B1 (fr) * 1984-01-10 1989-04-05 Bio-Industries Gmbh Sanofi Procédé de fabrication de képhyr
US4702923A (en) * 1985-10-08 1987-10-27 Sennosuke Tokumaru Lyophilized kefir yoghurt health food
US4902517A (en) * 1987-12-28 1990-02-20 The Calpis Food Industry Co., Ltd. Processes for producing milk-derived alcoholic beverages
JPH0626505B2 (ja) * 1988-06-16 1994-04-13 株式会社ヤクルト本社 ケフィア様乳製品の製造法
FR2672612B1 (fr) * 1991-02-08 1993-06-04 Rochade Procede de fabrication d'un nouveau levain lactique, nouveau levain obtenu, fabrication de produits alimentaires a partir de ce levain et produits obtenus.
JPH09191852A (ja) * 1996-01-19 1997-07-29 Sennosuke Tokumaru 健康食品
US5820903A (en) * 1997-06-30 1998-10-13 General Mills, Inc. Calcium fortified yogurt and methods of preparation
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof

Also Published As

Publication number Publication date
PT1085816E (pt) 2004-02-27
EP1085816B1 (fr) 2003-09-10
JP2002540807A (ja) 2002-12-03
JP4231208B2 (ja) 2009-02-25
DE60005104T2 (de) 2004-08-19
DK1085816T3 (da) 2004-01-26
HUP0103895A3 (en) 2003-02-28
SK18862000A3 (sk) 2001-06-11
NO20006284L (no) 2001-01-29
ATE249147T1 (de) 2003-09-15
KR20010072587A (ko) 2001-07-31
TR200003689T1 (tr) 2001-07-23
IL139853A0 (en) 2002-02-10
IS5741A (is) 2000-11-28
AR023477A1 (es) 2002-09-04
NO20006284D0 (no) 2000-12-11
US6511685B1 (en) 2003-01-28
PL344670A1 (en) 2001-11-19
CA2334877C (fr) 2009-06-16
DE60005104D1 (de) 2003-10-16
CA2334877A1 (fr) 2000-10-19
CN1300187A (zh) 2001-06-20
WO2000060950A1 (fr) 2000-10-19
ES2204569T3 (es) 2004-05-01
EE200000713A (et) 2002-04-15
HUP0103895A2 (hu) 2002-02-28
BR0006040A (pt) 2001-03-13
AU775104B2 (en) 2004-07-15
EP1085816A1 (fr) 2001-03-28
AU4311800A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
TNSN00078A1 (fr) Un supplement dietetique derivant de laits fermentes pour la prevention de l'osteoporose
AU2006204270B2 (en) Method of producing lactic acid bacterium having antiallergic effect
WO2006093267A1 (fr) Composition de fermentation presentant un effet immunomodulateur
CN102885163A (zh) 一种茯苓风味功能性奶酪饼及其制备方法
KR101025292B1 (ko) 효모에 의한 다시마 추출액의 기능성 천연 발효조미료 및 이의 제조방법
KR101025286B1 (ko) 다시마의 발효에 의한 다량의 ｇａｂａ를 함유한 발효산물 및 이를 이용한 기능성 천연 발효조미료와 다시마 발효분말의 제조 방법
CN114190561A (zh) 一种微胶囊化蜂王浆酶解多肽、其制备方法以及包含其的固体粉剂
JPH09173016A (ja) クロレラエキス粉末の製造法
JP2023106334A (ja) 乾燥藻体含有乾燥食品の製造方法、食品の製造方法、及び従属栄養性微細藻類の風味の改善方法
CN1480070A (zh) 新型螺旋藻保健食品及其生产方法
JP2006151952A (ja) 高脂血症乃至高尿酸血症改善剤、及び、健康食品
JPH11137207A (ja) 魚系調味料およびその製造方法
JP4852681B2 (ja) 腸管内細胞溶解活性抑制剤
KR101060514B1 (ko) 효모에 의한 다시마 발효산물로부터 기능성 천연 발효조미료와 다시마 발효분말 및 그의 제조방법
JP4339533B2 (ja) 健康食品の製造方法及び該方法によって得られた健康食品
JPS62257383A (ja) 天然ミネラルを豊富に含む乳酸菌の製造法
RU2802759C1 (ru) Способ получения морского биологического кальция из панцирных отходов креветки
JPS5959177A (ja) 納豆菌・乳酸菌含有食品
RU2379900C1 (ru) Способ получения нежирного сгущенного молока с сахаром
JP2004018522A (ja) 海洋ミネラルと乳酸菌共棲培養エキスからなる疾病予防及び治療組成物
JPH05103641A (ja) 褐藻類海藻分解物を利用した新規食品
JP3803531B2 (ja) 骨構成成分含有食品組成物及びこれを用いたカプセル型栄養補助食品
JP2001136933A (ja) 発酵加工食品及びその製造方法
CN107927796A (zh) 一种复合南极磷虾蛋白粉及其制备方法
JP2001078714A (ja) マグネシウム分補給用食品材料、及び、マグネシウム複合蛋白質及び／又はマグネシウム複合多糖蛋白質、並びに、それらの製造方法